Example: Heart Attack

Clinical Trials on Cysticercosis

Total 26 results

    • NCT00133458
      Withdrawn
      RCT ALB for SA Cysticercosis
      Conditions: Subarachnoid Cysticercosis
    • NCT00001205
      Recruiting
      Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
      Conditions: Cysticercosis
    • NCT02947581
      Recruiting
      Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)
      Conditions: Neurocysticercosis
    • NCT02243644
      Completed
      Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT
      Conditions: Neurocysticercosis
    • NCT03851419
      Unknown status
      The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania
      Conditions: Neurocysticercosis; HIV/AIDS
    • NCT00283699
      Completed
      A Pilot Study of Neurocysticercosis Treatment
      Conditions: Neurocysticercosis
    • NCT03834337
      Not yet recruiting
      Treatment of Patients With Active Neurocysticercosis in Eastern Africa
      Conditions: Neurocysticercosis
    • NCT02945527
      Terminated
      Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)
      Conditions: Neurocysticercosis
    • NCT02233855
      Terminated
      People Presenting With Neurocysticercosis in North America
      Conditions: Neurocysticercosis
    • NCT00001912
      Completed
      Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
      Conditions: Cysticercosis; Cysts; Seizures
    • NCT00290823
      Completed
      Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
      Conditions: Neurocysticercosis
    • NCT04706819
      Not yet recruiting
      Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study
      Conditions: Neurocysticercosis; Tropical Disease; Tenia Solium Infection
    • NCT03095339
      Completed
      EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso
      Conditions: Cysticercosis
    • NCT00527579
      Completed
      PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
      Conditions: Neurocysticercosis; Healthy
    • NCT00526916
      Completed
      PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28
      Conditions: Neurocysticercosis; Healthy
    • NCT00441285
      Completed
      Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
      Conditions: Neurocysticercosis; Epilepsy
    • NCT03950037
      Not yet recruiting
      SANCC: Clinical Trial Early Intervention
      Conditions: Subarachnoid Neurocysticercosis
    • NCT00004403
      Completed
      Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
      Conditions: Epilepsy; Cysticercosis
    • NCT02234570
      Completed
      Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
      Conditions: Neurocysticercosis
    • NCT01296958
      Completed
      Targeted Screening for Taenia Solium Tapeworms
      Conditions: Taenia Solium Taeniasis
    • NCT01368354
      Completed
      Taenia Solium Control Case Study in Zambia
      Conditions: Cysticercosis; Helminthiasis
    • NCT03874689
      Recruiting
      Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia
      Conditions: Neurocysticercosis; Taeniosis
    • NCT03808597
      Completed
      Digital Health Promotion in Iringa, Tanzania
      Conditions: HIV Infections; Tuberculosis; Cysticercosis; Tapeworm Pork
    • NCT01584362
      Withdrawn
      Single Ascending Dose Safety Study of Oxfendazole
      Conditions: Tenia Solium Infection
    • NCT00138359
      Terminated
      Mass Treatment T Solium Community Study
      Conditions: Intestinal Parasitism
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations